BSGM (BioSig Technologies) Change In Receivables : $0.02 Mil (TTM As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is BioSig Technologies Change In Receivables?

BioSig Technologies's change in receivables for the quarter that ended in Dec. 2024 was $-0.00 Mil. It means BioSig Technologies's Accounts Receivable increased by $0.00 Mil from Sep. 2024 to Dec. 2024 .

BioSig Technologies's change in receivables for the fiscal year that ended in Dec. 2024 was $0.02 Mil. It means BioSig Technologies's Accounts Receivable declined by $0.02 Mil from Dec. 2023 to Dec. 2024 .

BioSig Technologies's Accounts Receivable for the quarter that ended in Dec. 2024 was $0.11 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. BioSig Technologies's Days Sales Outstanding for the three months ended in Dec. 2024 was 765.10.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BioSig Technologies's liquidation value for the three months ended in Dec. 2024 was $-2.03 Mil.

BioSig Technologies Change In Receivables Historical Data

The historical data trend for BioSig Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioSig Technologies Change In Receivables Chart

BioSig Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-0.23

0.09

0.02

BioSig Technologies Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															0.02	0.04	-0.01	-	-

BioSig Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

BioSig Technologies (NAS:BSGM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

BioSig Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.109	/	0.013	*	91
=	765.10

2. In Ben Graham's calculation of liquidation value, BioSig Technologies's accounts receivable are only considered to be worth 75% of book value:

BioSig Technologies's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.155	-	2.264	+	0.75 * 0.109	+	0.5 * 0
=	-2.03

BioSig Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of BioSig Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

BioSig Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioSig Technologies Inc (NAS:BSGM) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

55 Greens Farms Road, 1st Floor, Westport, CT, USA, 06880

Website

https://www.biosig.com

BioSig Technologies Inc is a commercial-stage medical device company with an advanced digital signal processing technology platform to deliver insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), It is committed to addressing healthcare's biggest priorities saving time, saving costs, and saving lives. Its first product, the PURE EP System, is an FDA-cleared non-invasive class II device consisting of a unique combination of hardware and software designed to provide unprecedented signal clarity and precision for real-time visualization of intracardiac signals paving the way for personalized patient care.

Executives

Kenneth L Londoner	director, 10 percent owner	10 RED COAT ROAD, WESTPORT CT 06880
Steven J Buhaly	officer: Chief Financial Officer	1195 NW LOMPTON DRIVE, BEAVESTON OR 97006
John Sieckhaus	officer: Chief Operating Officer	C/O BIOSIG TECHNOLOGIES, 55 GREENS FARMS ROAD, WESTPORT CT 06880
Steve Chaussy	officer: Chief Financial Officer	9780 E AVE, HESPERIA CA 92345
Patrick Joseph Gallagher	director	275 PLEASANT HILL RD., FLANDERS NJ 07836
Gray Fleming	officer: Chief Commercial Officer	C/O BIOSIG TECHNOLOGIES, INC., 55 GREENS FARMS ROAD, WESTPORT CT 06880
James L Klein	director	2300NE BROOKWOOD PKWY, HILLSBORO OR 97124
Frederick Hrkac	director	C/O BIOSIG TECHNOLOGIES, 55 GREENS FARMS ROAD, WESTPORT CT 06880
James J Barry	director	C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV L3 6744832
Jeffrey F Odonnell	director	126 ROSSMORE DRIVE, MALVERN PA 19355
Anthony P. Zook	director	C/O VIVUS, INC., 351 EAST EVELYN AVENUE, MOUNTAIN VIEW CA 94041
Jerome B Zeldis	director	8767 E. VIA DE VENTURA, SUITE 190, SCOTTSDALE AZ 85258
Martha Pease	director	33 SEAVIEW, MADISON CT 06443
John M Kowalski	officer: VP of Sales	54 WILTON ROAD, 2ND FLOOR, WESTPORT CT 06880
Samuel E Navarro	director	C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044